Cookies help us run our site more efficiently.

By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information or to customize your cookie preferences.

A loophole in the EPA’s new sterilizer rule leaves warehouse workers vulnerable

News Feed
Friday, March 22, 2024

This story was produced in partnership with Atlanta News First. Thousands of warehouse workers across the U.S. are likely regularly exposed to the cancer-linked chemical ethylene oxide. More than half of the country’s medical equipment is sterilized with the compound, which the EPA considers a carcinogen. Ethylene oxide evaporates off the surface of these medical products after they’ve been sterilized, creating potentially dangerous concentrations of air pollution in the buildings where they’re stored. By and large, the EPA does not regulate these buildings — in fact, regulators don’t even know where most of them are. The Office of Safety and Health Administration, the federal agency in charge of worker protection that is known by its acronym, OSHA, has also done relatively little to evaluate worker exposure in these warehouses. But last week, OSHA opened a new investigation into a Georgia warehouse that stores medical devices sterilized with ethylene oxide, raising questions about whether the federal government is beginning to respond more quickly to these risks.  On March 13, the U.S. Marshals Service and the Douglas County sheriff’s office assisted OSHA in executing a search warrant at a warehouse leased by the medical device company ConMed in Lithia Springs, 17 miles west of Atlanta. The surprise inspection was initiated almost two weeks after a Grist and Atlanta News First investigation revealed that workers employed by ConMed had been unknowingly exposed to the chemical. Ambulances were routinely called to the facility as workers convulsed from seizures, lost consciousness, and had trouble breathing. The workers sued the company in 2020, but the lawsuit was ultimately dropped earlier this year after a judge dismissed some of their claims, citing state labor laws. (Under Georgia law, once employees seek workers’ compensation from the state, they are barred from suing employers separately.) ConMed denies the lawsuit’s allegations that it knowingly exposed workers to ethylene oxide and maintains that no individual medical emergency can be tied to exposure to the chemical. A company representative told Grist that it is “committed to fully complying” with all applicable regulations and conducts monthly ethylene oxide testing for its employees to review. “Given our many years of full cooperation with OSHA, as well as the fact that OSHA has inspected our Lithia Springs facility five times since 2019, ConMed was surprised by the manner in which OSHA elected to inspect the facility on March 13,” a company representative told Grist in an email. Ethylene oxide is a powerful fumigant, but it poses significant health risks and is linked to lung and breast cancers as well as diseases of the nervous system. Once medical devices are treated with ethylene oxide, the chemical continues to evaporate off the surface of the product as it moves through the supply chain. While the devices are trucked to warehouses, stored, and then shipped to hospitals, the products continue to quietly off-gas ethylene oxide, putting workers who come into contact with it at risk.  Read Next An invisible chemical is poisoning thousands of unsuspecting warehouse workers Naveena Sadasivam & Lylla Younes In a new rule it published last week, the EPA said that it will begin regulating toxic emissions from warehouses located on the same site as the sterilizer plants that actually apply the chemical. However, the agency argued that constraints stemming from the regulatory definition of the sterilization industry mean that offsite warehouses will be excluded from oversight. Even if the agency could clear that bureaucratic hurdle, it does not have “sufficient information to understand where these warehouses are located, who owns them, how they are operated, or what level of emissions potential they may have,” in the agency’s words. What little the EPA knows about the threat from offsite warehouses was gleaned from a study conducted by state regulators in Georgia. That effort initially identified seven off-site warehouses and found that at least one of the state’s warehouses was emitting more ethylene oxide than the sterilization plant that first treats the medical products before sending them out for storage. Federal officials will begin gathering data on warehouses, according to the new EPA rule, and use it to determine whether a completely new regulation governing storage facilities should be developed. Such a process could take years, according to experts who spoke to Grist. All the while, warehouse workers across the country will continue to inhale ethylene oxide, in many cases without their knowledge.  “Up until eight years ago, a lot of people had no idea that the sterilizer facility, which looks like your regular office park facility, was poisoning them,” said Marvin Brown, an attorney with the environmental nonprofit Earthjustice. “Now we have this additional issue of these warehouses that are continuing to poison people, and most people have no idea that they live next to one or work at one.” Brown and other experts Grist spoke to said the agency could take one of two approaches to regulating warehouses. It could expand the definition of regulated facilities under the sterilizer rule it finalized earlier this month, or it could create a new category of facilities that covers warehouses and develop a separate rule. Both come with challenges.  Reopening a new rule that has already been finalized is tricky, according to Scott Throwe, a former EPA enforcement official who worked on a number of rules that the EPA rolled out in the decade after amendments to the Clean Air Act were passed in 1990. “It’s a huge can of worms,” he said. “Once you open a rule, then you have to fix this and you have to fix this. It snowballs.” Alternatively, the EPA could draft a new rule entirely, he added, but the agency is unlikely to do that either, because of the sheer amount of effort such a process would take. Throwe said that the EPA’s decision not to include offsite warehouse regulations in its new rule means that the agency doesn’t have either the time, the resources, or the will to tackle those emissions at this time. “They’re going to declare victory on this one and move on,” he said. “They ain’t reopening that rule unless someone sues them.” A spokesperson for the EPA said that the agency has an “incomplete list” of warehouses and that it has not conducted any risk assessments of them. As a next step, the agency expects to follow up with sterilization companies that did not provide detailed information about the location of their warehouses in response to a 2021 request. Once those responses are received, the agency plans to conduct emissions testing at some of the warehouses. If the agency decides to pursue a separate rule for warehouses, that process could take four to five years, the spokesperson said.  More than 50 percent of all U.S. medical supplies are sterilized by ethylene oxide. Getty Images The rule governing medical sterilization facilities was one of the first industry-specific air quality regulations that the EPA ever crafted. In its amendments to the Clean Air Act in 1990, Congress published a list of 189 toxic air pollutants and asked the agency to develop regulations for each industry emitting at least one of them. Officials published the first standards for medical sterilizers in 1994 with little fanfare, according to Throwe. At the time, regulators and toxicologists were unaware of the true risks of ethylene oxide, which was used to fumigate a range of materials, from books to spices to cosmetics. With the new law giving the agency just a decade to craft dozens of new regulations, officials rushed the process, sacrificing the efficacy of some standards along the way. “It was like drinking from a firehose,” Throwe said. “Unrealistic statutory deadlines became court-ordered deadlines.” Drafting new regulations for a polluting industry, regulators quickly learned, was a lot of work. In addition to collecting and analyzing copious amounts of data on a particular type of plant’s emissions and configuration, officials had to consult engineering experts to understand what kinds of technologies they could ask companies to use to control their emissions. Decades later, the process for revising these regulations to better protect exposed communities is no different. It took the EPA almost a decade to publish its new sterilizer regulations, and it did so under a court-ordered due date after missing a previous deadline to update the rule. If the agency were to issue a new rule for warehouses, the time and resource commitment would be steep, Throwe said. While the EPA is not responsible for worker safety, it has found a roundabout way to increase protections for those coming in close contact with ethylene oxide. Since ethylene oxide is a fumigant, the agency is also pursuing separate oversight under a federal pesticide law. The Federal Insecticide, Fungicide, and Rodenticide Act requires the agency to evaluate pesticides every 15 years and determine where, how, and how much of a given pesticide may be used. In April, the EPA proposed a new set of requirements including reducing the amount of ethylene oxide used for sterilization and mandating that workers wear protective equipment while engaging in tasks where there is a high risk of exposure to the chemical. Since the law applies to all facilities where ethylene oxide is used — not just sterilization plants — warehouse workers could benefit from the requirements once it is finalized.   Some state and local agencies are proactively regulating warehouses themselves. After the Georgia Environmental Protection Division found that one warehouse was estimated to emit about nine times as much ethylene oxide as the facility that sterilized it, the agency began trying to find similarly dangerous warehouses. After scouring the internet and reaching out to companies, the agency identified four warehouses that were emitting more ethylene oxide than permitted under state law. The agency is now in the process of issuing permits and requiring controls for those facilities.  In Southern California, which has a large concentration of sterilization facilities, the local air quality regulator has included requirements for offsite warehouses in a rule that primarily targets sterilization plants. The rule categorizes warehouses into two tiers — those with an indoor space of 250,000 square feet or more and those with between 100,000 and 250,000 square feet. Depending on the size of the facility, the warehouses are subject to different reporting and monitoring requirements. In the course of developing the rule, the agency identified 28 warehouses that fall into one of these two tiers. The agency finalized the rule in December, and larger warehouses will be studied for a year to determine whether they emit significant amounts of ethylene oxide. Editor’s note: Earthjustice is an advertiser with Grist. Advertisers have no role in Grist’s editorial decisions. This story was originally published by Grist with the headline A loophole in the EPA’s new sterilizer rule leaves warehouse workers vulnerable on Mar 22, 2024.

"They’re going to declare victory on this one and move on."

This story was produced in partnership with Atlanta News First.

Thousands of warehouse workers across the U.S. are likely regularly exposed to the cancer-linked chemical ethylene oxide. More than half of the country’s medical equipment is sterilized with the compound, which the EPA considers a carcinogen. Ethylene oxide evaporates off the surface of these medical products after they’ve been sterilized, creating potentially dangerous concentrations of air pollution in the buildings where they’re stored.

By and large, the EPA does not regulate these buildings — in fact, regulators don’t even know where most of them are. The Office of Safety and Health Administration, the federal agency in charge of worker protection that is known by its acronym, OSHA, has also done relatively little to evaluate worker exposure in these warehouses. But last week, OSHA opened a new investigation into a Georgia warehouse that stores medical devices sterilized with ethylene oxide, raising questions about whether the federal government is beginning to respond more quickly to these risks. 

On March 13, the U.S. Marshals Service and the Douglas County sheriff’s office assisted OSHA in executing a search warrant at a warehouse leased by the medical device company ConMed in Lithia Springs, 17 miles west of Atlanta. The surprise inspection was initiated almost two weeks after a Grist and Atlanta News First investigation revealed that workers employed by ConMed had been unknowingly exposed to the chemical. Ambulances were routinely called to the facility as workers convulsed from seizures, lost consciousness, and had trouble breathing.

The workers sued the company in 2020, but the lawsuit was ultimately dropped earlier this year after a judge dismissed some of their claims, citing state labor laws. (Under Georgia law, once employees seek workers’ compensation from the state, they are barred from suing employers separately.) ConMed denies the lawsuit’s allegations that it knowingly exposed workers to ethylene oxide and maintains that no individual medical emergency can be tied to exposure to the chemical. A company representative told Grist that it is “committed to fully complying” with all applicable regulations and conducts monthly ethylene oxide testing for its employees to review.

“Given our many years of full cooperation with OSHA, as well as the fact that OSHA has inspected our Lithia Springs facility five times since 2019, ConMed was surprised by the manner in which OSHA elected to inspect the facility on March 13,” a company representative told Grist in an email.

Ethylene oxide is a powerful fumigant, but it poses significant health risks and is linked to lung and breast cancers as well as diseases of the nervous system. Once medical devices are treated with ethylene oxide, the chemical continues to evaporate off the surface of the product as it moves through the supply chain. While the devices are trucked to warehouses, stored, and then shipped to hospitals, the products continue to quietly off-gas ethylene oxide, putting workers who come into contact with it at risk. 

In a new rule it published last week, the EPA said that it will begin regulating toxic emissions from warehouses located on the same site as the sterilizer plants that actually apply the chemical. However, the agency argued that constraints stemming from the regulatory definition of the sterilization industry mean that offsite warehouses will be excluded from oversight. Even if the agency could clear that bureaucratic hurdle, it does not have “sufficient information to understand where these warehouses are located, who owns them, how they are operated, or what level of emissions potential they may have,” in the agency’s words.

What little the EPA knows about the threat from offsite warehouses was gleaned from a study conducted by state regulators in Georgia. That effort initially identified seven off-site warehouses and found that at least one of the state’s warehouses was emitting more ethylene oxide than the sterilization plant that first treats the medical products before sending them out for storage. Federal officials will begin gathering data on warehouses, according to the new EPA rule, and use it to determine whether a completely new regulation governing storage facilities should be developed. Such a process could take years, according to experts who spoke to Grist. All the while, warehouse workers across the country will continue to inhale ethylene oxide, in many cases without their knowledge. 

“Up until eight years ago, a lot of people had no idea that the sterilizer facility, which looks like your regular office park facility, was poisoning them,” said Marvin Brown, an attorney with the environmental nonprofit Earthjustice. “Now we have this additional issue of these warehouses that are continuing to poison people, and most people have no idea that they live next to one or work at one.”

Brown and other experts Grist spoke to said the agency could take one of two approaches to regulating warehouses. It could expand the definition of regulated facilities under the sterilizer rule it finalized earlier this month, or it could create a new category of facilities that covers warehouses and develop a separate rule. Both come with challenges. 

Reopening a new rule that has already been finalized is tricky, according to Scott Throwe, a former EPA enforcement official who worked on a number of rules that the EPA rolled out in the decade after amendments to the Clean Air Act were passed in 1990. “It’s a huge can of worms,” he said. “Once you open a rule, then you have to fix this and you have to fix this. It snowballs.”

Alternatively, the EPA could draft a new rule entirely, he added, but the agency is unlikely to do that either, because of the sheer amount of effort such a process would take. Throwe said that the EPA’s decision not to include offsite warehouse regulations in its new rule means that the agency doesn’t have either the time, the resources, or the will to tackle those emissions at this time.

“They’re going to declare victory on this one and move on,” he said. “They ain’t reopening that rule unless someone sues them.”

A spokesperson for the EPA said that the agency has an “incomplete list” of warehouses and that it has not conducted any risk assessments of them. As a next step, the agency expects to follow up with sterilization companies that did not provide detailed information about the location of their warehouses in response to a 2021 request. Once those responses are received, the agency plans to conduct emissions testing at some of the warehouses. If the agency decides to pursue a separate rule for warehouses, that process could take four to five years, the spokesperson said. 

Stock photo of a surgical tray containing medical equipment
More than 50 percent of all U.S. medical supplies are sterilized by ethylene oxide. Getty Images

The rule governing medical sterilization facilities was one of the first industry-specific air quality regulations that the EPA ever crafted. In its amendments to the Clean Air Act in 1990, Congress published a list of 189 toxic air pollutants and asked the agency to develop regulations for each industry emitting at least one of them. Officials published the first standards for medical sterilizers in 1994 with little fanfare, according to Throwe. At the time, regulators and toxicologists were unaware of the true risks of ethylene oxide, which was used to fumigate a range of materials, from books to spices to cosmetics. With the new law giving the agency just a decade to craft dozens of new regulations, officials rushed the process, sacrificing the efficacy of some standards along the way.

“It was like drinking from a firehose,” Throwe said. “Unrealistic statutory deadlines became court-ordered deadlines.”

Drafting new regulations for a polluting industry, regulators quickly learned, was a lot of work. In addition to collecting and analyzing copious amounts of data on a particular type of plant’s emissions and configuration, officials had to consult engineering experts to understand what kinds of technologies they could ask companies to use to control their emissions. Decades later, the process for revising these regulations to better protect exposed communities is no different. It took the EPA almost a decade to publish its new sterilizer regulations, and it did so under a court-ordered due date after missing a previous deadline to update the rule. If the agency were to issue a new rule for warehouses, the time and resource commitment would be steep, Throwe said.

While the EPA is not responsible for worker safety, it has found a roundabout way to increase protections for those coming in close contact with ethylene oxide. Since ethylene oxide is a fumigant, the agency is also pursuing separate oversight under a federal pesticide law. The Federal Insecticide, Fungicide, and Rodenticide Act requires the agency to evaluate pesticides every 15 years and determine where, how, and how much of a given pesticide may be used. In April, the EPA proposed a new set of requirements including reducing the amount of ethylene oxide used for sterilization and mandating that workers wear protective equipment while engaging in tasks where there is a high risk of exposure to the chemical. Since the law applies to all facilities where ethylene oxide is used — not just sterilization plants — warehouse workers could benefit from the requirements once it is finalized.  

Some state and local agencies are proactively regulating warehouses themselves. After the Georgia Environmental Protection Division found that one warehouse was estimated to emit about nine times as much ethylene oxide as the facility that sterilized it, the agency began trying to find similarly dangerous warehouses. After scouring the internet and reaching out to companies, the agency identified four warehouses that were emitting more ethylene oxide than permitted under state law. The agency is now in the process of issuing permits and requiring controls for those facilities. 

In Southern California, which has a large concentration of sterilization facilities, the local air quality regulator has included requirements for offsite warehouses in a rule that primarily targets sterilization plants. The rule categorizes warehouses into two tiers — those with an indoor space of 250,000 square feet or more and those with between 100,000 and 250,000 square feet. Depending on the size of the facility, the warehouses are subject to different reporting and monitoring requirements. In the course of developing the rule, the agency identified 28 warehouses that fall into one of these two tiers. The agency finalized the rule in December, and larger warehouses will be studied for a year to determine whether they emit significant amounts of ethylene oxide.

Editor’s note: Earthjustice is an advertiser with Grist. Advertisers have no role in Grist’s editorial decisions.

This story was originally published by Grist with the headline A loophole in the EPA’s new sterilizer rule leaves warehouse workers vulnerable on Mar 22, 2024.

Read the full story here.
Photos courtesy of

Forever Chemicals' Might Triple Teens' Risk Of Fatty Liver Disease

By Dennis Thompson HealthDay ReporterTHURSDAY, Jan. 8, 2026 (HealthDay News) — PFAS “forever chemicals” might nearly triple a young person’s risk...

By Dennis Thompson HealthDay ReporterTHURSDAY, Jan. 8, 2026 (HealthDay News) — PFAS “forever chemicals” might nearly triple a young person’s risk of developing fatty liver disease, a new study says.Each doubling in blood levels of the PFAS chemical perfluorooctanoic acid is linked to 2.7 times the odds of fatty liver disease among teenagers, according to findings published in the January issue of the journal Environmental Research.Fatty liver disease — also known as metabolic dysfunction-associated steatotic liver disease (MASLD) — occurs when fat builds up in the organ, leading to inflammation, scarring and increased risk of cancer.About 10% of all children, and up to 40% of children with obesity, have fatty liver disease, researchers said in background notes.“MASLD can progress silently for years before causing serious health problems,” said senior researcher Dr. Lida Chatzi, a professor of population and public health sciences and pediatrics at the Keck School of Medicine of USC in Los Angeles.“When liver fat starts accumulating in adolescence, it may set the stage for a lifetime of metabolic and liver health challenges,” Chatzi added in a news release. “If we reduce PFAS exposure early, we may help prevent liver disease later. That’s a powerful public health opportunity.”Per- and polyfluoroalkyl substances (PFAS) are called “forever chemicals” because they combine carbon and fluorine molecules, one of the strongest chemical bonds possible. This makes PFAS removal and breakdown very difficult.PFAS compounds have been used in consumer products since the 1940s, including fire extinguishing foam, nonstick cookware, food wrappers, stain-resistant furniture and waterproof clothing.More than 99% of Americans have measurable PFAS in their blood, and at least one PFAS chemical is present in roughly half of U.S. drinking water supplies, researchers said.“Adolescents are particularly more vulnerable to the health effects of PFAS as it is a critical period of development and growth,” lead researcher Shiwen “Sherlock” Li, an assistant professor of public health sciences at the University of Hawaii, said in a news release.“In addition to liver disease, PFAS exposure has been associated with a range of adverse health outcomes, including several types of cancer,” Li said.For the new study, researchers examined data on 284 Southern California adolescents and young adults gathered as part of two prior USC studies.All of the participants already had a high risk of metabolic disease because their parents had type 2 diabetes or were overweight, researchers said.Their PFAS levels were measured through blood tests, and liver fat was assessed using MRI scans.Higher blood levels of two common PFAS — perfluorooctanoic acid (PFOA) and perfluoroheptanoic acid (PFHpA) — were linked to an increased risk of fatty liver disease.Results showed a young person’s risk was even higher if they smoked or carried a genetic variant known to influence liver fat.“These findings suggest that PFAS exposures, genetics and lifestyle factors work together to influence who has greater risk of developing MASLD as a function of your life stage,” researcher Max Aung, assistant professor of population and public health sciences at the Keck School of Medicine, said in a news release.“Understanding gene and environment interactions can help advance precision environmental health for MASLD,” he added.The study also showed that fatty liver disease became more common as teens grew older, adding to evidence that younger people might be more vulnerable to PFAS exposure, Chatzi said.“PFAS exposures not only disrupt liver biology but also translate into real liver disease risk in youth,” Chatzi said. “Adolescence seems to be a critical window of susceptibility, suggesting PFAS exposure may matter most when the liver is still developing.”The Environmental Working Group has more on PFAS.SOURCES: Keck School of Medicine of USC, news release, Jan. 6, 2026; Environmental Research, Jan. 1, 2026Copyright © 2026 HealthDay. All rights reserved.

China Announces Another New Trade Measure Against Japan as Tensions Rise

China has escalated its trade tensions with Japan by launching an investigation into imported dichlorosilane, a chemical gas used in making semiconductors

BEIJING (AP) — China escalated its trade tensions with Japan on Wednesday by launching an investigation into imported dichlorosilane, a chemical gas used in making semiconductors, a day after it imposed curbs on the export of so-called dual-use goods that could be used by Japan’s military.The Chinese Commerce Ministry said in a statement that it had launched the investigation following an application from the domestic industry showing the price of dichlorosilane imported from Japan had decreased 31% between 2022 and 2024.“The dumping of imported products from Japan has damaged the production and operation of our domestic industry,” the ministry said.The measure comes a day after Beijing banned exports to Japan of dual-use goods that can have military applications.Beijing has been showing mounting displeasure with Tokyo after new Japanese Prime Minister Sanae Takaichi suggested late last year that her nation's military could intervene if China were to take action against Taiwan — an island democracy that Beijing considers its own territory.Tensions were stoked again on Tuesday when Japanese lawmaker Hei Seki, who last year was sanctioned by China for “spreading fallacies” about Taiwan and other disputed territories, visited Taiwan and called it an independent country. Also known as Yo Kitano, he has been banned from entering China. He told reporters that his arrival in Taiwan demonstrated the two are “different countries.”“I came to Taiwan … to prove this point, and to tell the world that Taiwan is an independent country,” Hei Seki said, according to Taiwan’s Central News Agency.“The nasty words of a petty villain like him are not worth commenting on,” Chinese Foreign Ministry spokesperson Mao Ning retorted when asked about his comment. Fears of a rare earths curb Masaaki Kanai, head of Asia Oceanian Affairs at Japan's Foreign Ministry, urged China to scrap the trade curbs, saying a measure exclusively targeting Japan that deviates from international practice is unacceptable. Japan, however, has yet to announce any retaliatory measures.As the two countries feuded, speculation rose that China might target rare earths exports to Japan, in a move similar to the rounds of critical minerals export restrictions it has imposed as part of its trade war with the United States.China controls most of the global production of heavy rare earths, used for making powerful, heat-resistance magnets used in industries such as defense and electric vehicles.While the Commerce Ministry did not mention any new rare earths curbs, the official newspaper China Daily, seen as a government mouthpiece, quoted anonymous sources saying Beijing was considering tightening exports of certain rare earths to Japan. That report could not be independently confirmed. Improved South Korean ties contrast with Japan row As Beijing spars with Tokyo, it has made a point of courting a different East Asian power — South Korea.On Wednesday, South Korean President Lee Jae Myung wrapped up a four-day trip to China – his first since taking office in June. Lee and Chinese President Xi Jinping oversaw the signing of cooperation agreements in areas such as technology, trade, transportation and environmental protection.As if to illustrate a contrast with the China-Japan trade frictions, Lee joined two business events at which major South Korean and Chinese companies pledged to collaborate.The two sides signed 24 export contracts worth a combined $44 million, according to South Korea’s Ministry of Trade, Industry and Resources. During Lee’s visit, Chinese media also reported that South Korea overtook Japan as the leading destination for outbound flights from China’s mainland over the New Year’s holiday.China has been discouraging travel to Japan, saying Japanese leaders’ comments on Taiwan have created “significant risks to the personal safety and lives of Chinese citizens in Japan.”Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.Photos You Should See – December 2025

Pesticide industry ‘immunity shield’ stripped from US appropriations bill

Democrats and the Make America Healthy Again movement pushed back on the rider in a funding bill led by BayerIn a setback for the pesticide industry, Democrats have succeeded in removing a rider from a congressional appropriations bill that would have helped protect pesticide makers from being sued and could have hindered state efforts to warn about pesticide risks.Chellie Pingree, a Democratic representative from Maine and ranking member of the House appropriations interior, environment, and related agencies subcommittee, said Monday that the controversial measure pushed by the agrochemical giant Bayer and industry allies has been stripped from the 2026 funding bill. Continue reading...

In a setback for the pesticide industry, Democrats have succeeded in removing a rider from a congressional appropriations bill that would have helped protect pesticide makers from being sued and could have hindered state efforts to warn about pesticide risks.Chellie Pingree, a Democratic representative from Maine and ranking member of the House appropriations interior, environment, and related agencies subcommittee, said Monday that the controversial measure pushed by the agrochemical giant Bayer and industry allies has been stripped from the 2026 funding bill.The move is final, as Senate Republican leaders have agreed not to revisit the issue, Pingree said.“I just drew a line in the sand and said this cannot stay in the bill,” Pingree told the Guardian. “There has been intensive lobbying by Bayer. This has been quite a hard fight.”The now-deleted language was part of a larger legislative effort that critics say is aimed at limiting litigation against pesticide industry leader Bayer, which sells the widely used Roundup herbicides.An industry alliance set up by Bayer has been pushing for both state and federal laws that would make it harder for consumers to sue over pesticide risks to human health and has successfully lobbied for the passing of such laws in Georgia and North Dakota so far.The specific proposed language added to the appropriations bill blocked federal funds from being used to “issue or adopt any guidance or any policy, take any regulatory action, or approve any labeling or change to such labeling” inconsistent with the conclusion of an Environmental Protection Agency (EPA) human health assessment.Critics said the language would have impeded states and local governments from warning about risks of pesticides even in the face of new scientific findings about health harms if such warnings were not consistent with outdated EPA assessments. The EPA itself would not be able to update warnings without finalizing a new assessment, the critics said.And because of the limits on warnings, critics of the rider said, consumers would have found it difficult, if not impossible, to sue pesticide makers for failing to warn them of health risks if the EPA assessments do not support such warnings.“This provision would have handed pesticide manufacturers exactly what they’ve been lobbying for: federal preemption that stops state and local governments from restricting the use of harmful, cancer-causing chemicals, adding health warnings, or holding companies accountable in court when people are harmed,” Pingree said in a statement. “It would have meant that only the federal government gets a say – even though we know federal reviews can take years, and are often subject to intense industry pressure.”Pingree tried but failed to overturn the language in a July appropriations committee hearing.Bayer, the key backer of the legislative efforts, has been struggling for years to put an end to thousands of lawsuits filed by people who allege they developed cancer from their use of Roundup and other glyphosate-based weed killers sold by Bayer. The company inherited the litigation when it bought Monsanto in 2018 and has paid out billions of dollars in settlements and jury verdicts but still faces several thousand ongoing lawsuits. Bayer maintains its glyphosate-based herbicides do not cause cancer and are safe when used as directed.When asked for comment on Monday, Bayer said that no company should have “blanket immunity” and it disputed that the appropriations bill language would have prevented anyone from suing pesticide manufacturers. The company said it supports state and federal legislation “because the future of American farming depends on reliable science-based regulation of important crop protection products – determined safe for use by the EPA”.The company additionally states on its website that without “legislative certainty”, lawsuits over its glyphosate-based Roundup and other weed killers can impact its research and product development and other “important investments”.Pingree said her efforts were aided by members of the Make America Healthy Again (Maha) movement who have spent the last few months meeting with congressional members and their staffers on this issue. She said her team reached out to Maha leadership in the last few days to pressure Republican lawmakers.“This is the first time that we’ve had a fairly significant advocacy group working on the Republican side,” she said.Last week, Zen Honeycutt, a Maha leader and founder of the group Moms Across America, posted a “call to action”, urging members to demand elected officials “Stop the Pesticide Immunity Shield”.“A lot of people helped make this happen,” Honeycutt said. “Many health advocates have been fervently expressing their requests to keep chemical companies accountable for safety … We are delighted that our elected officials listened to so many Americans who spoke up and are restoring trust in the American political system.”Pingree said the issue is not dead. Bayer has “made this a high priority”, and she expects to see continued efforts to get industry friendly language inserted into legislation, including into the new Farm Bill.“I don’t think this is over,” she said.This story is co-published with the New Lede, a journalism project of the Environmental Working Group

Forever Chemicals' Common in Cosmetics, but FDA Says Safety Data Are Scant

By Deanna Neff HealthDay ReporterSATURDAY, Jan. 3, 2026 (HealthDay News) — Federal regulators have released a mandated report regarding the...

By Deanna Neff HealthDay ReporterSATURDAY, Jan. 3, 2026 (HealthDay News) — Federal regulators have released a mandated report regarding the presence of "forever chemicals" in makeup and skincare products. Forever chemicals — known as perfluoroalkyl and polyfluoroalkyl substances or PFAS — are manmade chemicals that don't break down and have built up in people’s bodies and the environment. They are sometimes added to beauty products intentionally, and sometimes they are contaminants. While the findings confirm that PFAS are widely used in the beauty industry, the U.S. Food and Drug Administration (FDA) admitted it lacks enough scientific evidence to determine if they are truly safe for consumers.The new report reveals that 51 forever chemicals — are used in 1,744 cosmetic formulations. These synthetic chemicals are favored by manufacturers because they make products waterproof, increase their durability and improve texture.FDA scientists focused their review on the 25 most frequently used PFAS, which account for roughly 96% of these chemicals found in beauty products. The results were largely unclear. While five were deemed to have low safety concerns, one was flagged for potential health risks, and safety of the rest could not be confirmed.FDA Commissioner Dr. Marty Makary expressed concern over the difficulty in accessing private research. “Our scientists found that toxicological data for most PFAS are incomplete or unavailable, leaving significant uncertainty about consumer safety,” Makary said in a news release, adding that “this lack of reliable data demands further research.”Despite growing concerns about their potential toxicity, no federal laws specifically ban their use in cosmetics.The FDA report focuses on chemicals that are added to products on purpose, rather than those that might show up as accidental contaminants. Moving forward, FDA plans to work closely with the U.S. Centers for Disease Control and Prevention (CDC) and the Environmental Protection Agency (EPA) to update and strengthen recommendations on PFAS across the retail and food supply chain, Makary said. The agency has vowed to devote more resources to monitoring these chemicals and will take enforcement action if specific products are proven to be dangerous.The U.S. Food and Drug Administration provides updates and consumer guidance on the use of PFAS in cosmetics.SOURCE: U.S. Food and Drug Administration, news release, Dec. 29, 2025Copyright © 2026 HealthDay. All rights reserved.

Suggested Viewing

Join us to forge
a sustainable future

Our team is always growing.
Become a partner, volunteer, sponsor, or intern today.
Let us know how you would like to get involved!

CONTACT US

sign up for our mailing list to stay informed on the latest films and environmental headlines.

Subscribers receive a free day pass for streaming Cinema Verde.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.